Back to top
more

Chimera Investment (CIM)

(Delayed Data from NYSE)

$13.22 USD

13.22
943,654

-0.35 (-2.58%)

Updated Aug 6, 2025 04:00 PM ET

After-Market: $13.24 +0.02 (0.15%) 6:46 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (158 out of 246)

Industry: REIT and Equity Trust

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Should You Invest in the Invesco KBW High Dividend Yield Financial ETF (KBWD)?

by Zacks Equity Research

Sector ETF report for KBWD

Zacks Equity Research

New Residential (NRZ) Closes Caliber Buyout, Hikes Dividend

by Zacks Equity Research

New Residential (NRZ) hikes its third-quarter dividends by 25%, following the acquisition of Caliber, which poses the company to expand mortgage operations.

Zacks Equity Research

NexPoint (NREF) Announces Public Offering of Common Stock

by Zacks Equity Research

Net proceeds from NexPoint's (NREF) 2-million share offering is expected to be used for life science and self-storage preferred investments.

Zacks Equity Research

What Makes Chimera Investment (CIM) a Strong Momentum Stock: Buy Now?

by Zacks Equity Research

Does Chimera Investment (CIM) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Equity Research

Is Chimera Investment (CIM) Stock Outpacing Its Finance Peers This Year?

by Zacks Equity Research

Is (CIM) Outperforming Other Finance Stocks This Year?

Zacks Equity Research

Chimera (CIM) Upgraded to Buy: Here's What You Should Know

by Zacks Equity Research

Chimera (CIM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

Chimera Investment (CIM) Beats Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Chimera (CIM) delivered earnings and revenue surprises of 45.95% and 39.33%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Chimera (CIM) to Report Q2 Earnings: What's in the Offing?

by Zacks Equity Research

While securitizations in the prior quarters are likely to have provided stable interest income for Chimera (CIM) in Q2, a challenging backdrop for Agency securities is likely to have hurt valuations.

Zacks Equity Research

Annaly (NLY) Q2 Earnings Beat Estimates, NII & Book Value Dip

by Zacks Equity Research

Annaly's (NLY) second-quarter results reflect a rise in the average yield on interest-earning assets and financing costs, while book value erosion ail.

Zacks Equity Research

Chimera Investment (CIM) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Should You Invest in the Invesco KBW High Dividend Yield Financial ETF (KBWD)?

by Zacks Equity Research

Sector ETF report for KBWD

Zacks Equity Research

AGNC Investment (AGNC) Beats on Q2 Net Spread and Dollar Roll

by Zacks Equity Research

While higher prepayments and a decline in asset yields hinder AGNC Investment's (AGNC) Q2 results, expansion in net interest spread has been a positive.

Zacks Equity Research

Top Ranked Income Stocks to Buy for June 22nd

by Zacks Equity Research

CIM, XOM, NAVI, and LCNB made it to the Zacks Rank #1 (Strong Buy) income stocks list on June 22, 2021

Zacks Equity Research

Zacks Industry Outlook Highlights: Annaly Capital Management, Chimera Investment Corp and Granite Point Mortgage Trust

by Zacks Equity Research

Zacks Industry Outlook Highlights: Annaly Capital Management, Chimera Investment Corp and Granite Point Mortgage Trust

Devyani Chamria headshot

3 Promising mREIT Stocks to Buy From the Prospering Industry

by Devyani Chamria

With the Fed's continued support and favorable backdrop for credit market, Zacks REIT and Equity Trust industry players like NLY, CIM and GPMT are poised to enjoy near-term benefits.

Zacks Equity Research

Here's Why You Should Hold on to AGNC Investment (AGNC) Stock Now

by Zacks Equity Research

While AGNC Investment's (AGNC) prudent asset-selection efforts offer greater stability of cash flows, high prepayment speed continues to hinder its performance.

Zacks Equity Research

Chimera Investment (CIM) Is Up 1.77% in One Week: What You Should Know

by Zacks Equity Research

Does Chimera Investment (CIM) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Equity Research

Chimera Investment (CIM) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Chimera (CIM) delivered earnings and revenue surprises of 16.13% and 12.83%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Chimera Investment (CIM) Enters Overbought Territory: Is A Drop Coming?

by Zacks Equity Research

Chimera Investment (CIM) has moved higher as of late, but there could definitely be trouble on the horizon for this company

Zacks Equity Research

Chimera Investment (CIM) Misses Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Chimera (CIM) delivered earnings and revenue surprises of -9.38% and -5.80%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Chimera Investment (CIM) Beats Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Chimera (CIM) delivered earnings and revenue surprises of 6.45% and 11.93%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Here's How Chimera (CIM) Looks Just Ahead of Q3 Earnings

by Zacks Equity Research

Low LIBOR rates during the third quarter are likely to lead to have reduced interest income for Chimera's (CIM) floating-rate investments.

Zacks Equity Research

Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.